AST Letter to MolDX: Molecular Testing for Solid Organ Allograft Rejection

Wednesday, April 5, 2023

The AST recently submitted a letter to MolDX regarding the recent decision to limit reimbursement coverage for molecular diagnostics for transplantation such as donor derived cell free (cf)DNA and gene expression profiling.

To view the letter, click here.